House passes AHA-supported bill to combat deadly synthetic drugs
The House of Representatives last night voted 258-101 to pass the Synthetic Drug Control Act (H.R. 3537). The AHA-supported legislation would give the Drug Enforcement Administration authority to stop the distribution, sale and use of additional synthetic drugs by classifying them as Schedule I controlled substances. Since 2012, when 26 types of synthetic drugs were added to Schedule I, “many new synthetic substances have entered the market, leading to devastating health consequences and increased mortality, particularly among the nation’s youth,” AHA noted last year in a letter of support for the bill.
Related News Articles
Headline
The Centers for Medicare & Medicaid Services has approved a Section 1115 Medicaid demonstration waiver allowing West Virginia to expand its benefits…
Headline
Eliminating the Medicaid Institutions for Mental Disease exclusion for adults under age 65 would help improve access to treatment for those with severe or…
Headline
One death a day in Maine is caused by an opioid overdose. Bridgton family practice physician Craig Smith, M.D., a member of the Bridgton Hospital medical staff…
Headline
The Centers for Medicare & Medicaid Services seeks comments through Nov. 20 on a “new direction” for its Innovation Center that will approach…
Headline
The Substance Abuse and Mental Health Services Administration Friday awarded $144.1 million in grants to states, cities, health care providers and community…
Headline
The Centers for Disease Control and Prevention today released a report offering guidance and resources to help health care providers, response and recovery…